Amgen
Is Amgen the Debt-Driven King of Return on Equity?
Can Amgen's stunning ROE of 53% keep leading the pack despite its high debt? Let’s dive into the numbers!
See moreCan Amgen's stunning ROE of 53% keep leading the pack despite its high debt? Let’s dive into the numbers!
See more